ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.06 Million USD | -45.68% |
| 2022 | 7.48 Million USD | -8.61% |
| 2021 | 8.18 Million USD | -63.74% |
| 2020 | 22.57 Million USD | 45.16% |
| 2019 | 15.55 Million USD | 6.43% |
| 2018 | 14.61 Million USD | 18.42% |
| 2017 | 12.33 Million USD | 200.78% |
| 2016 | 4.1 Million USD | -48.17% |
| 2015 | 7.91 Million USD | 2.49% |
| 2014 | 7.72 Million USD | -34.05% |
| 2013 | 11.7 Million USD | -17.66% |
| 2012 | 14.22 Million USD | 14.27% |
| 2011 | 12.44 Million USD | 38.59% |
| 2010 | 8.98 Million USD | -15.55% |
| 2009 | 10.63 Million USD | -36.98% |
| 2008 | 16.87 Million USD | 22.55% |
| 2007 | 13.76 Million USD | 83.83% |
| 2006 | 7.49 Million USD | -21.87% |
| 2005 | 9.58 Million USD | 0.0% |
| 2003 | 1.38 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.69 Million USD | -9.03% |
| 2024 Q2 | 3.35 Million USD | -9.17% |
| 2023 Q1 | 8.59 Million USD | 14.88% |
| 2023 FY | 4.06 Million USD | -45.68% |
| 2023 Q4 | 4.06 Million USD | -14.33% |
| 2023 Q3 | 4.74 Million USD | -7.24% |
| 2023 Q2 | 5.11 Million USD | -40.49% |
| 2022 Q4 | 7.48 Million USD | -0.43% |
| 2022 Q2 | 9.56 Million USD | 10.61% |
| 2022 Q1 | 8.64 Million USD | 5.61% |
| 2022 FY | 7.48 Million USD | -8.61% |
| 2022 Q3 | 7.51 Million USD | -21.43% |
| 2021 Q1 | 23.3 Million USD | 3.26% |
| 2021 FY | 8.18 Million USD | -63.74% |
| 2021 Q3 | 11.47 Million USD | -81.45% |
| 2021 Q2 | 61.88 Million USD | 165.49% |
| 2021 Q4 | 8.18 Million USD | -28.68% |
| 2020 Q2 | 17.99 Million USD | 12.51% |
| 2020 FY | 22.57 Million USD | 45.16% |
| 2020 Q1 | 15.99 Million USD | 2.83% |
| 2020 Q4 | 22.57 Million USD | 15.71% |
| 2020 Q3 | 19.5 Million USD | 8.43% |
| 2019 Q3 | 59.84 Million USD | 97.52% |
| 2019 FY | 15.55 Million USD | 6.43% |
| 2019 Q4 | 15.55 Million USD | -74.02% |
| 2019 Q1 | 18.85 Million USD | 29.02% |
| 2019 Q2 | 30.29 Million USD | 60.73% |
| 2018 Q3 | 11 Million USD | -3.48% |
| 2018 Q1 | 12.69 Million USD | 2.89% |
| 2018 FY | 14.61 Million USD | 18.42% |
| 2018 Q4 | 14.61 Million USD | 32.76% |
| 2018 Q2 | 11.4 Million USD | -10.18% |
| 2017 Q1 | 3.76 Million USD | -8.23% |
| 2017 FY | 12.33 Million USD | 200.78% |
| 2017 Q4 | 12.33 Million USD | 198.31% |
| 2017 Q3 | 4.13 Million USD | -8.39% |
| 2017 Q2 | 4.51 Million USD | 19.94% |
| 2016 Q3 | 9.42 Million USD | -49.34% |
| 2016 Q4 | 4.1 Million USD | -56.46% |
| 2016 FY | 4.1 Million USD | -48.17% |
| 2016 Q2 | 18.59 Million USD | 15.41% |
| 2016 Q1 | 16.11 Million USD | 103.62% |
| 2015 Q4 | 7.91 Million USD | 8.89% |
| 2015 FY | 7.91 Million USD | 2.49% |
| 2015 Q1 | 7.02 Million USD | -9.08% |
| 2015 Q3 | 7.26 Million USD | 12.63% |
| 2015 Q2 | 6.45 Million USD | -8.1% |
| 2014 Q4 | 7.72 Million USD | -8.28% |
| 2014 FY | 7.72 Million USD | -34.05% |
| 2014 Q3 | 8.41 Million USD | -13.53% |
| 2014 Q2 | 9.73 Million USD | -5.66% |
| 2014 Q1 | 10.32 Million USD | -11.85% |
| 2013 Q2 | 13.03 Million USD | -10.2% |
| 2013 Q1 | 14.52 Million USD | 2.1% |
| 2013 Q4 | 11.7 Million USD | -4.52% |
| 2013 FY | 11.7 Million USD | -17.66% |
| 2013 Q3 | 12.26 Million USD | -5.95% |
| 2012 Q2 | 13.33 Million USD | 41.5% |
| 2012 Q4 | 14.22 Million USD | 2.23% |
| 2012 FY | 14.22 Million USD | 14.27% |
| 2012 Q1 | 9.42 Million USD | -24.29% |
| 2012 Q3 | 13.91 Million USD | 4.34% |
| 2011 Q4 | 12.44 Million USD | 27.86% |
| 2011 Q2 | 8.64 Million USD | 2.39% |
| 2011 Q3 | 9.73 Million USD | 12.61% |
| 2011 FY | 12.44 Million USD | 38.59% |
| 2011 Q1 | 8.44 Million USD | -6.0% |
| 2010 Q2 | 8.87 Million USD | -11.8% |
| 2010 Q4 | 8.98 Million USD | -0.61% |
| 2010 Q1 | 10.05 Million USD | -5.41% |
| 2010 FY | 8.98 Million USD | -15.55% |
| 2010 Q3 | 9.03 Million USD | 1.85% |
| 2009 FY | 10.63 Million USD | -36.98% |
| 2009 Q2 | 27.32 Million USD | 49.53% |
| 2009 Q4 | 10.63 Million USD | -57.95% |
| 2009 Q3 | 25.28 Million USD | -7.47% |
| 2009 Q1 | 18.27 Million USD | 8.3% |
| 2008 Q2 | 13.59 Million USD | 7.1% |
| 2008 Q4 | 16.87 Million USD | 28.26% |
| 2008 Q3 | 13.15 Million USD | -3.24% |
| 2008 FY | 16.87 Million USD | 22.55% |
| 2008 Q1 | 12.69 Million USD | -7.8% |
| 2007 FY | 13.76 Million USD | 83.83% |
| 2007 Q4 | 13.76 Million USD | 18.13% |
| 2007 Q3 | 11.65 Million USD | 0.0% |
| 2006 Q4 | 7.49 Million USD | 0.0% |
| 2006 FY | 7.49 Million USD | -21.87% |
| 2005 FY | 9.58 Million USD | 0.0% |
| 2005 Q4 | 9.58 Million USD | 0.0% |
| 2003 FY | 1.38 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 92.071% |
| BrainsWay Ltd. | 15.31 Million USD | 73.462% |
| Cerus Corporation | 144.3 Million USD | 97.184% |
| Envoy Medical, Inc. | 9.4 Million USD | 56.775% |
| electroCore, Inc. | 8.94 Million USD | 54.567% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 23.924% |
| IceCure Medical Ltd | 4.24 Million USD | 4.309% |
| Inogen, Inc. | 121.38 Million USD | 96.652% |
| OrthoPediatrics Corp. | 72.56 Million USD | 94.399% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 86.261% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -27.721% |
| MaxCyte, Inc. | 36.1 Million USD | 88.745% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -119.924% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -855.603% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.756% |
| PAVmed Inc | 57.13 Million USD | 92.887% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 84.04% |
| RxSight, Inc. | 22.18 Million USD | 81.684% |
| Sight Sciences, Inc. | 46.43 Million USD | 91.248% |
| SI-BONE, Inc. | 61.05 Million USD | 93.343% |
| TELA Bio, Inc. | 59.16 Million USD | 93.131% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 96.434% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 60.616% |
| Acutus Medical, Inc. | 54.83 Million USD | 92.589% |
| Talis Biomedical Corporation | 29.22 Million USD | 86.094% |
| Spectral AI, Inc. | 12.4 Million USD | 67.228% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 82.433% |
| CVRx, Inc. | 39.28 Million USD | 89.654% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 66.015% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -67.291% |
| Bioventus Inc. | 589.79 Million USD | 99.311% |
| Venus Concept Inc. | 107.1 Million USD | 96.206% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 92.134% |
| LivaNova PLC | 1.15 Billion USD | 99.647% |
| 908 Devices Inc. | 37.49 Million USD | 89.16% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.422% |
| Nemaura Medical Inc. | 26.37 Million USD | 84.593% |
| NeuroPace, Inc. | 86.99 Million USD | 95.329% |
| LENSAR, Inc. | 22.4 Million USD | 81.864% |
| Apyx Medical Corporation | 52.31 Million USD | 92.232% |
| Cutera, Inc. | 518.12 Million USD | 99.216% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 86.143% |
| BioSig Technologies, Inc. | 4.68 Million USD | 13.255% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 93.037% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 81.087% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.815% |
| Axonics, Inc. | 82.35 Million USD | 95.066% |
| Outset Medical, Inc. | 190.91 Million USD | 97.871% |
| IRIDEX Corporation | 24.91 Million USD | 83.688% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 96.722% |
| IRadimed Corporation | 20.73 Million USD | 80.401% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -142.772% |
| INVO Bioscience, Inc. | 19.99 Million USD | 79.675% |
| Telesis Bio, Inc. | 40.87 Million USD | 90.057% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 90.037% |
| Varex Imaging Corporation | 668.6 Million USD | 99.392% |
| Quipt Home Medical Corp. | 136.29 Million USD | 97.018% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -13.774% |
| Pulmonx Corporation | 60.63 Million USD | 93.298% |
| Dynatronics Corporation | 11.78 Million USD | 65.501% |
| Modular Medical, Inc. | 2.27 Million USD | -78.873% |
| Semler Scientific, Inc. | 6.27 Million USD | 35.183% |
| InMode Ltd. | 75.91 Million USD | 94.647% |
| Bruker Corporation | 2.83 Billion USD | 99.857% |
| Cytosorbents Corporation | 29.98 Million USD | 86.447% |
| DexCom, Inc. | 4.19 Billion USD | 99.903% |
| Align Technology, Inc. | 2.45 Billion USD | 99.834% |
| Viveve Medical, Inc. | 10.84 Million USD | 62.533% |
| ZimVie Inc. | 795.85 Million USD | 99.489% |
| Movano Inc. | 5.97 Million USD | 31.949% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 96.115% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -855.603% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 66.015% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.364% |
| Profound Medical Corp. | 12.66 Million USD | 67.914% |
| Insulet Corporation | 1.85 Billion USD | 99.781% |
| enVVeno Medical Corporation | 2.43 Million USD | -66.899% |
| Surmodics, Inc. | 65.82 Million USD | 93.826% |
| iCAD, Inc. | 8 Million USD | 49.206% |
| Nuwellis, Inc. | 6.78 Million USD | 40.059% |
| Biotricity, Inc. | 35.91 Million USD | 88.686% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.178% |
| Aethlon Medical, Inc. | 2.47 Million USD | -63.894% |
| InspireMD, Inc. | 8.14 Million USD | 50.086% |
| PAVmed Inc. | 57.13 Million USD | 92.887% |
| BIOLASE, Inc. | 35.34 Million USD | 88.503% |
| Beyond Air, Inc. | 29.77 Million USD | 86.351% |
| FONAR Corporation | 57.45 Million USD | 92.927% |
| AxoGen, Inc. | 101.16 Million USD | 95.983% |
| Vivani Medical, Inc. | 25.03 Million USD | 83.767% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 95.371% |
| Inari Medical, Inc. | 209.32 Million USD | 98.059% |
| UFP Technologies, Inc. | 118.04 Million USD | 96.557% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 67.976% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -85.926% |
| Tenon Medical, Inc. | 5.56 Million USD | 26.998% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -128.443% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 76.954% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.871% |
| Sintx Technologies, Inc. | 6.59 Million USD | 38.359% |
| NanoVibronix, Inc. | 2.68 Million USD | -51.303% |
| Quanterix Corporation | 78.08 Million USD | 94.795% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -13.774% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 16.807% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.611% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.286% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 75.638% |
| NeuroMetrix, Inc. | 1.33 Million USD | -204.848% |
| Hyperfine, Inc. | 9.8 Million USD | 58.531% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 98.376% |
| Biomerica, Inc. | 2.66 Million USD | -52.61% |
| Bone Biologics Corporation | 831.4 Thousand USD | -388.813% |
| AVITA Medical, Inc. | 19.86 Million USD | 79.542% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -105.909% |
| Silk Road Medical, Inc | 114.15 Million USD | 96.44% |